Clinical Trial: Phase 1b
This study is evaluating clinical complete response (cCR) rates to NG-350A in combination with chemoradiotherapy (CRT) in adult patients with locally advanced rectal cancer (LARC) and at least one risk factor for local or distant recurrence.
Commitment to Patients
This study is evaluating clinical complete response (cCR) rates to NG-350A in combination with chemoradiotherapy (CRT) in adult patients with locally advanced rectal cancer (LARC) and at least one risk factor for local or distant recurrence.
FORTRESS Study Fact Sheets
Resources
Akamis Bio is partnering with colorectal cancer advocacy organizations to provide patients and their families with critical resources and support. These groups offer disease education, tools to navigate treatment options, information about clinical studies, opportunities to connect with the CRC community, and much more. Following are links to several leading CRC-focused advocacy organizations:
